Heterozygous  ||| S:0 E:13 ||| JJ
frameshift  ||| S:13 E:24 ||| JJ
mutation  ||| S:24 E:33 ||| NN
in  ||| S:33 E:36 ||| IN
keratin  ||| S:36 E:44 ||| CD
5  ||| S:44 E:46 ||| CD
in  ||| S:46 E:49 ||| IN
a  ||| S:49 E:51 ||| DT
family  ||| S:51 E:58 ||| NN
with  ||| S:58 E:63 ||| IN
Galli-Galli  ||| S:63 E:75 ||| JJ
disease  ||| S:75 E:83 ||| NN
Reticulate  ||| S:83 E:94 ||| NNP
pigmentary  ||| S:94 E:105 ||| NN
disorders  ||| S:105 E:115 ||| NNS
include  ||| S:115 E:123 ||| VBP
the  ||| S:123 E:127 ||| DT
rare  ||| S:127 E:132 ||| JJ
autosomal  ||| S:132 E:142 ||| JJ
dominant  ||| S:142 E:151 ||| JJ
Galli-Galli  ||| S:151 E:163 ||| JJ
disease  ||| S:163 E:171 ||| NN
( ||| S:171 E:172 ||| -LRB-
GGD ||| S:172 E:175 ||| NNP
)  ||| S:175 E:177 ||| -RRB-
and  ||| S:177 E:181 ||| CC
Dowling-Degos  ||| S:181 E:195 ||| JJ
disease  ||| S:195 E:203 ||| NN
( ||| S:203 E:204 ||| -LRB-
DDD ||| S:204 E:207 ||| NNP
) ||| S:207 E:208 ||| -RRB-
.  ||| S:208 E:210 ||| .
Clinical  ||| S:210 E:219 ||| JJ
diagnosis  ||| S:219 E:229 ||| NN
between  ||| S:229 E:237 ||| IN
some  ||| S:237 E:242 ||| DT
of  ||| S:242 E:245 ||| IN
the  ||| S:245 E:249 ||| DT
subtypes  ||| S:249 E:258 ||| NN
can  ||| S:258 E:262 ||| MD
be  ||| S:262 E:265 ||| VB
difficult  ||| S:265 E:275 ||| JJ
due  ||| S:275 E:279 ||| JJ
to  ||| S:279 E:282 ||| TO
a  ||| S:282 E:284 ||| DT
degree  ||| S:284 E:291 ||| NN
of  ||| S:291 E:294 ||| IN
overlap  ||| S:294 E:302 ||| NN
between  ||| S:302 E:310 ||| IN
clinical  ||| S:310 E:319 ||| JJ
features ||| S:319 E:327 ||| NNS
,  ||| S:327 E:329 ||| ,
therefore  ||| S:329 E:339 ||| RB
analysis  ||| S:339 E:348 ||| NN
at  ||| S:348 E:351 ||| IN
the  ||| S:351 E:355 ||| DT
molecular  ||| S:355 E:365 ||| JJ
level  ||| S:365 E:371 ||| NN
may  ||| S:371 E:375 ||| MD
be  ||| S:375 E:378 ||| VB
necessary  ||| S:378 E:388 ||| JJ
to  ||| S:388 E:391 ||| TO
confirm  ||| S:391 E:399 ||| VB
the  ||| S:399 E:403 ||| DT
diagnosis ||| S:403 E:412 ||| NN
.  ||| S:412 E:414 ||| .
To  ||| S:414 E:417 ||| TO
identify  ||| S:417 E:426 ||| VB
the  ||| S:426 E:430 ||| DT
underlying  ||| S:430 E:441 ||| JJ
genetic  ||| S:441 E:449 ||| JJ
defect  ||| S:449 E:456 ||| NN
in  ||| S:456 E:459 ||| IN
a  ||| S:459 E:461 ||| DT
48-year-old  ||| S:461 E:473 ||| JJ
Asian-American  ||| S:473 E:488 ||| JJ
woman  ||| S:488 E:494 ||| NN
with  ||| S:494 E:499 ||| IN
a  ||| S:499 E:501 ||| DT
clinical  ||| S:501 E:510 ||| JJ
diagnosis  ||| S:510 E:520 ||| NN
of  ||| S:520 E:523 ||| IN
GGD ||| S:523 E:526 ||| NNP
.  ||| S:526 E:528 ||| .
Histological  ||| S:528 E:541 ||| JJ
analysis  ||| S:541 E:550 ||| NN
was  ||| S:550 E:554 ||| VBD
performed  ||| S:554 E:564 ||| VBN
on  ||| S:564 E:567 ||| IN
a  ||| S:567 E:569 ||| DT
skin  ||| S:569 E:574 ||| NN
biopsy  ||| S:574 E:581 ||| VBZ
using  ||| S:581 E:587 ||| VBG
haematoxylin-eosin  ||| S:587 E:606 ||| JJ
staining ||| S:606 E:614 ||| NN
.  ||| S:614 E:616 ||| .
KRT5  ||| S:616 E:621 ||| NNP
( ||| S:621 E:622 ||| -LRB-
the  ||| S:622 E:626 ||| DT
gene  ||| S:626 E:631 ||| NN
encoding  ||| S:631 E:640 ||| VBD
keratin  ||| S:640 E:648 ||| CD
5 ||| S:648 E:649 ||| CD
)  ||| S:649 E:651 ||| -RRB-
was  ||| S:651 E:655 ||| VBD
amplified  ||| S:655 E:665 ||| VBN
from  ||| S:665 E:670 ||| IN
genomic  ||| S:670 E:678 ||| JJ
DNA  ||| S:678 E:682 ||| NN
and  ||| S:682 E:686 ||| CC
directly  ||| S:686 E:695 ||| RB
sequenced ||| S:695 E:704 ||| VBN
.  ||| S:704 E:706 ||| .
The  ||| S:706 E:710 ||| DT
patient  ||| S:710 E:718 ||| NN
had  ||| S:718 E:722 ||| VBD
a  ||| S:722 E:724 ||| DT
history  ||| S:724 E:732 ||| NN
of  ||| S:732 E:735 ||| IN
pruritus  ||| S:735 E:744 ||| NN
and  ||| S:744 E:748 ||| CC
hyperpigmented  ||| S:748 E:763 ||| JJ
erythematous  ||| S:763 E:776 ||| JJ
macules  ||| S:776 E:784 ||| NN
and  ||| S:784 E:788 ||| CC
thin  ||| S:788 E:793 ||| JJ
papules  ||| S:793 E:801 ||| NN
along  ||| S:801 E:807 ||| IN
the  ||| S:807 E:811 ||| DT
flexor  ||| S:811 E:818 ||| JJ
surfaces  ||| S:818 E:827 ||| NN
of  ||| S:827 E:830 ||| IN
her  ||| S:830 E:834 ||| PRP$
arms ||| S:834 E:838 ||| NNS
,  ||| S:838 E:840 ||| ,
her  ||| S:840 E:844 ||| PRP$
upper  ||| S:844 E:850 ||| JJ
back  ||| S:850 E:855 ||| NN
and  ||| S:855 E:859 ||| CC
neck ||| S:859 E:863 ||| NN
,  ||| S:863 E:865 ||| ,
axillae  ||| S:865 E:873 ||| NN
and  ||| S:873 E:877 ||| CC
inframammary  ||| S:877 E:890 ||| JJ
areas ||| S:890 E:895 ||| NNS
.  ||| S:895 E:897 ||| .
Hypopigmented  ||| S:897 E:911 ||| JJ
macules  ||| S:911 E:919 ||| NN
were  ||| S:919 E:924 ||| VBD
seen  ||| S:924 E:929 ||| VBN
among  ||| S:929 E:935 ||| IN
the  ||| S:935 E:939 ||| DT
hyperpigmentation ||| S:939 E:956 ||| NN
.  ||| S:956 E:958 ||| .
A  ||| S:958 E:960 ||| DT
heterozygous  ||| S:960 E:973 ||| FW
1-bp  ||| S:973 E:978 ||| FW
insertion  ||| S:978 E:988 ||| FW
mutation  ||| S:988 E:997 ||| FW
in  ||| S:997 E:1000 ||| FW
KRT5  ||| S:1000 E:1005 ||| FW
( ||| S:1005 E:1006 ||| -LRB-
c.38dupG ||| S:1006 E:1014 ||| NNP
;  ||| S:1014 E:1016 ||| :
p.Ser14GlnfsTer3 ||| S:1016 E:1032 ||| CD
)  ||| S:1032 E:1034 ||| -RRB-
was  ||| S:1034 E:1038 ||| VBD
identified  ||| S:1038 E:1049 ||| VBN
in  ||| S:1049 E:1052 ||| IN
the  ||| S:1052 E:1056 ||| DT
proband ||| S:1056 E:1063 ||| NN
.  ||| S:1063 E:1065 ||| .
This  ||| S:1065 E:1070 ||| DT
mutation  ||| S:1070 E:1079 ||| NN
occurs  ||| S:1079 E:1086 ||| VBZ
within  ||| S:1086 E:1093 ||| IN
the  ||| S:1093 E:1097 ||| DT
head  ||| S:1097 E:1102 ||| NN
domain  ||| S:1102 E:1109 ||| NN
of  ||| S:1109 E:1112 ||| IN
the  ||| S:1112 E:1116 ||| DT
keratin  ||| S:1116 E:1124 ||| JJ
5  ||| S:1124 E:1126 ||| CD
protein  ||| S:1126 E:1134 ||| NN
leading  ||| S:1134 E:1142 ||| VBG
to  ||| S:1142 E:1145 ||| TO
a  ||| S:1145 E:1147 ||| DT
frameshift  ||| S:1147 E:1158 ||| NN
and  ||| S:1158 E:1162 ||| CC
premature  ||| S:1162 E:1172 ||| JJ
stop  ||| S:1172 E:1177 ||| NN
codon ||| S:1177 E:1182 ||| NN
.  ||| S:1182 E:1184 ||| .
From  ||| S:1184 E:1189 ||| IN
the  ||| S:1189 E:1193 ||| DT
histological  ||| S:1193 E:1206 ||| JJ
findings  ||| S:1206 E:1215 ||| NNS
and  ||| S:1215 E:1219 ||| CC
mutation  ||| S:1219 E:1228 ||| JJ
analysis  ||| S:1228 E:1237 ||| NN
the  ||| S:1237 E:1241 ||| DT
individual  ||| S:1241 E:1252 ||| NN
was  ||| S:1252 E:1256 ||| VBD
identified  ||| S:1256 E:1267 ||| VBN
as  ||| S:1267 E:1270 ||| IN
having  ||| S:1270 E:1277 ||| VBG
GGD  ||| S:1277 E:1281 ||| NNP
due  ||| S:1281 E:1285 ||| JJ
to  ||| S:1285 E:1288 ||| TO
haploinsufficiency  ||| S:1288 E:1307 ||| VB
of  ||| S:1307 E:1310 ||| IN
keratin  ||| S:1310 E:1318 ||| CD
5 ||| S:1318 E:1319 ||| CD
.  ||| S:1319 E:1321 ||| .
